HIGH

Meridian Bioscience Recalls Revogene C. difficile Assay Over False-Negative Risk

Meridian Bioscience recalled 211 units of the Revogene C. difficile diagnostic assay on December 5, 2025. Users may experience false-negative results due to a decline in performance over time. Patients and healthcare providers must stop using the device immediately.

Quick Facts at a Glance

Recall Date
December 5, 2025
Hazard Level
HIGH
Brand
Meridian Bioscience
Category
Health & Personal Care
Sold At
Multiple Retailers
Geographic Scope
1 states
At-Risk Groups
GENERAL

Hazard Information

The affected lots show a decline in performance over time, which may lead to false-negative results.

What You Should Do

Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact Meridian Bioscience Inc or your healthcare provider for instructions. Notification method: Letter

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

About This Product

The Revogene C. difficile assay is used to diagnose C. difficile infections, which can lead to severe gastrointestinal issues. Healthcare providers rely on accurate test results for effective treatment.

Why This Is Dangerous

The decline in performance over time may prevent the assay from detecting the presence of C. difficile, resulting in false-negative results. This could lead to misdiagnosis and lack of essential treatment for patients.

Industry Context

This recall is not part of a broader industry pattern.

Real-World Impact

Consumers may face health risks due to potential misdiagnosis. Delayed treatment for C. difficile infections can lead to serious health complications.

Practical Guidance

How to identify if yours is affected

  1. Locate the catalog number 410300 on the product packaging.
  2. Check the lot numbers: 410300U195, 410300U196, 410300U197, 410300U201.
  3. If your product matches these details, it is affected by the recall.

Where to find product info

The catalog and lot numbers are typically found on the product packaging or on the label attached to the assay.

What timeline to expect

Expect a refund processing timeline of approximately 4-6 weeks after returning the product.

If the manufacturer is unresponsive

  • Document your communications with the company.
  • Reach out again via phone or email.
  • Consider filing a complaint with the FDA if no response is received.

How to prevent similar issues

  • When purchasing medical devices, verify the manufacturer's reputation and recall history.
  • Always check for recent recalls before using diagnostic devices.
  • Consult healthcare professionals for alternative testing options if necessary.

Documentation advice

Keep records of your product details, receipts, and any correspondence with the manufacturer regarding the recall.

Product Details

The recalled product is the Revogene C. difficile in vitro diagnostic assay with Catalog Number 410300. It was distributed nationwide in the US and in Italy. The affected lot numbers are 410300U195, 410300U196, 410300U197, and 410300U201.

Key Facts

  • 211 units recalled
  • False-negative risk due to performance decline
  • Affected lots: 410300U195, 410300U196, 410300U197, 410300U201
  • Nationwide distribution in the US and Italy
  • Stop using the device immediately

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: What to Do When You Find a Recalled Product

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelHIGH
Severity Score
8/ 10
Affected Groups
GENERAL
Injury Types
OTHER

Product Classification

Product Details

Model Numbers
UDI-DI: 00840733102349
Lot Numbers: 410300U195
410300U196
410300U197
410300U201
Affected States
ALL
Report Date
January 14, 2026
Recall Status
ACTIVE

Related Recalls

Vehicles & Parts
HIGH

Mazda CX-70 Recall 2025 for Powertrain Control Module Software May Lose Drive Power

Mazda North American Operations is recalling 2024 CX-90 and 2025 CX-70 SUVs sold through Mazda dealers. The PCM and ECM software can illuminate malfunction indicator lights and cause a loss of drive power, increasing crash risk. Owner notification letters were mailed December 19, 2024, and Mazda will reprogram the PCM and ECM at no charge.

Mazda
Loss of
Read more
Vehicles & Parts
HIGH

Nissan Kicks 2025 Certification Label Recall for GVWR/GAWR Errors (PD136, PMA47)

Nissan North America is recalling certain 2025 Nissan Kicks vehicles sold through Nissan dealers nationwide. The certification label may print incorrect GVWR and GAWR values, risking overload. Some SR trims with a 19-inch wheel package may display an incorrect wheel size on the label, and owners should contact their Nissan dealer to arrange replacement labels.

Nissan
An overloaded
Read more